Education
About Us
Working with TipRanks
Follow Us
Neil Allan Johnson Insider Profile
4 Followers
Neil Allan Johnson, Chief Executive Officer at Duke Capital, holds 7.89M shares in Duke Capital (Ticker: GB:DUKE), holds 1.06M shares in Marvel Biosciences Corp (Ticker: TSE:MRVL), holds 875.00K shares in Thiogenesis Therapeutics Corp (Ticker: TSE:TTI).
Neil Allan Johnson Duke Capital (DUKE)Chief Executive Officer
Duke Capital (DUKE)
Chief Executive Officer
Ranked #26,153 out of 102,971 Corporate Insiders
Profitable Transactions
9 out of 16 Profitable Transactions
Average Return
+3.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Neil Allan Johnson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Neil Allan Johnson
Neil Allan Johnson's Trading History
Duke Capital
Aug 01, 2025
Chief Executive Officer
Uninformative Buy
―
£2.37M
Difference Cap Financial
Apr 16, 2014
―
Informative Buy
93.75K
C$2.61M
Canaccord Genuity
Mar 30, 2012
Senior Officer
Uninformative Buy
1.98K
$1.18M
Marvel Biosciences Corp
Apr 15, 2025
Director
Informative Buy
75.38K
C$190.44K
Thiogenesis Therapeutics Corp
Apr 01, 2022
Executive, Ten Percent Owner
Uninformative Sell
12.50K
C$673.75K
List of latest transactions for each holding click on a transaction to see Neil Allan Johnson's performance on stock
You May Also Like
Neil Allan Johnson insider profile FAQ
What is the percentage of profitable transactions made by Neil Allan Johnson?
The percentage of profitable transactions made by Neil Allan Johnson is 56%.
What is the average return per transaction made by Neil Allan Johnson?
The average return per transaction made by Neil Allan Johnson is 3.20%.
What stocks does Neil Allan Johnson hold?
Neil Allan Johnson holds: GB:DUKE, TSE:DCF, CCORF, TSE:MRVL, TSE:TTI stocks.
What was Neil Allan Johnson’s latest transaction?
Neil Allan Johnson latest transaction was an Uninformative Buy of ―.
What was Neil Allan Johnson's most profitable transaction?
Neil Allan Johnson’s most profitable transaction was an Informative Buy of TSE:MRVL stock on April 15, 2025. The return on the trade was 89.40%.
What is Neil Allan Johnson's role in Duke Capital?
Neil Allan Johnson's role in Duke Capital is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.